Sara Gullickson was recently named one of the 20 women set to dominate the international cannabis space in 2019. Taken from the Benzinga article:
Not long ago, the cannabis industry could take pride in the higher-than-usual percentage of C-suite positions occupied by women, with roughly 1-in-3 of these posts held by a woman. This number plummeted in just a couple of years, however, dropping from 36 percent in 2015 to 27 percent in 2017, according to a Marijuana Business Daily survey.
Fortunately, many of the women who are in positions of power within the cannabis industry are fighting back, fiercely seeking to advance female representation in the industry. In an attempt to honor them, Benzinga is highlighting 20 women set to dominate the international cannabis space in 2019.
Sara Gullickson is the CEO of Item 9 Labs Corp, which specializes in the development and manufacturing of innovative cannabis products and proprietary delivery platforms. Along with her role at Item 9 Labs, Gullickson is the owner of Strive Wellness of Nevada, a 20,000-square-foot medical cannabis cultivation and processing facility, and the dispensary Strive Life of North Dakota.
Gullickson previously served as CEO and founder of Dispensary Permits, an international cannabis consulting firm that she established in 2010 at age 26. Dispensary Permits secured cannabis licenses across more than a dozen state markets and five countries. In 2018, Dispensary Permits and its assets were acquired by Item 9 Labs.
Commenting on female leadership, Gullickson said: “The female point of view is often undermined or undervalued. Sometimes, I think it is easy for women to operate behind the scenes because we wear so many hats in our day-to-day lives. However, we are needed at all of the big decision tables. Our approach is equally relevant and essential to the longevity of a project. Moving forward, it should be a priority to blend both the masculine and feminine perspective, not emphasize one over the other.”